is a cancer that happens inside your eyeball. It’s rare. Just 7 out of every 1 million people get it each year. But it’s also the most common eye cancer for adults. Sometimes the disease can ...
On paper, it might sound irrational to blame yourself for a rare eye cancer diagnosis. But spend a few minutes in the online ...
Dec. 18, 2024 My son Jack was diagnosed in 2022 with retinoblastoma, a malignant childhood cancer of the central nervous system that originates and grows in the eye. If left untreated, it ...
Clinical Trials Arena on MSN10d
iOnctura doses first subject in Phase II uveal melanoma treatment trialOnctura has dosed the first subject in the open-label Phase II OCULE-01 trial of oral roginolisib in individuals with rare eye cancer, metastatic uveal melanoma (UM). The randomised, parallel-arm ...
A phase 3 trial plans to further assess neoadjuvant darovasertib for the potential treatment of patients with primary uveal ...
Hundreds of people in England with a rare form of cancer affecting the eye will soon be able to access a pioneering therapy based on T-cell receptor (TCR) technology, developed by Immunocore.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback